OM1 provides technology and expertise to enable healthcare organizations and other stakeholders to collect and leverage valid outcomes data, which is the key to improving our healthcare system.

OM1 is a leading healthcare technology company focused on providing outcomes measurement and predictive analytics for value-based and personalized healthcare. Leveraging big clinical data, standardized outcomes measures, and artificial intelligence technology, OM1 delivers a scientifically robust and clinically meaningful approach to enable stakeholders across the healthcare ecosystem to improve clinical and financial outcomes with more precise information for better decision-making.

Investor
Location
Boston
GC backed since
2014
IPO

Related Perspectives

No items found.